EQL Pharma AB (publ) (STO:EQL)
Sweden
· Delayed Price · Currency is SEK 82.90
+0.80 (0.97%)
At close: May 12, 2025
EQL Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is April - March.
Millions SEK. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| Cash & Equivalents | 82.4 | 20.47 | 44.43 | 41.2 | 26.58 | Upgrade
|
| Cash & Short-Term Investments | 82.4 | 20.47 | 44.43 | 41.2 | 26.58 | Upgrade
|
| Cash Growth | 302.58% | -53.93% | 7.83% | 55.01% | 157.80% | Upgrade
|
| Accounts Receivable | 125.68 | 60.77 | 51.7 | 34.1 | 22.08 | Upgrade
|
| Other Receivables | 13.14 | 5.21 | 0.96 | 0.71 | 4.22 | Upgrade
|
| Receivables | 138.82 | 65.98 | 52.66 | 34.81 | 26.3 | Upgrade
|
| Inventory | 179.03 | 105.63 | 65.37 | 41.67 | 42.36 | Upgrade
|
| Prepaid Expenses | - | 4.75 | 4.2 | 2.24 | 0.32 | Upgrade
|
| Other Current Assets | - | 0.94 | 0.57 | 3.53 | 2.27 | Upgrade
|
| Total Current Assets | 400.25 | 197.77 | 167.23 | 123.45 | 97.82 | Upgrade
|
| Property, Plant & Equipment | 6.32 | 2.67 | 3.15 | 4.19 | 5.01 | Upgrade
|
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Intangible Assets | 402.25 | 149.08 | 102.54 | 98.41 | 93.68 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | - | 0.3 | Upgrade
|
| Long-Term Deferred Charges | - | 24.24 | 12.78 | 11.83 | 6.7 | Upgrade
|
| Total Assets | 808.82 | 373.76 | 285.7 | 237.89 | 203.51 | Upgrade
|
| Accounts Payable | 90.94 | 49.83 | 29.61 | 15.98 | 19.03 | Upgrade
|
| Accrued Expenses | - | 6.65 | 17.87 | 16.28 | 4.48 | Upgrade
|
| Short-Term Debt | 109.74 | 102.22 | 63.7 | 59.32 | 64.41 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | 5.4 | 5.4 | Upgrade
|
| Current Portion of Leases | - | 1.4 | 1.21 | - | - | Upgrade
|
| Current Income Taxes Payable | - | 0.52 | 0.14 | - | - | Upgrade
|
| Other Current Liabilities | 19.96 | 1.43 | 4.66 | 1.64 | 1.48 | Upgrade
|
| Total Current Liabilities | 220.63 | 162.05 | 117.19 | 98.76 | 94.93 | Upgrade
|
| Long-Term Debt | 341.82 | 15.45 | - | 7.2 | 12.6 | Upgrade
|
| Long-Term Leases | - | 1.02 | 1.71 | 4.18 | 4.76 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 25.34 | 17.51 | 12.05 | 4.12 | - | Upgrade
|
| Other Long-Term Liabilities | -0 | - | 0 | - | - | Upgrade
|
| Total Liabilities | 587.79 | 196.03 | 130.94 | 114.26 | 112.29 | Upgrade
|
| Common Stock | 221.03 | 1.31 | 1.31 | 1.31 | 1.31 | Upgrade
|
| Additional Paid-In Capital | - | 67.45 | 67.18 | 66.99 | 66.13 | Upgrade
|
| Retained Earnings | - | 108.97 | 86.26 | 55.33 | 23.78 | Upgrade
|
| Comprehensive Income & Other | - | -0 | - | - | - | Upgrade
|
| Shareholders' Equity | 221.03 | 177.73 | 154.75 | 123.63 | 91.22 | Upgrade
|
| Total Liabilities & Equity | 808.82 | 373.76 | 285.7 | 237.89 | 203.51 | Upgrade
|
| Total Debt | 451.56 | 120.09 | 66.62 | 76.1 | 87.17 | Upgrade
|
| Net Cash (Debt) | -369.16 | -99.63 | -22.19 | -34.9 | -60.59 | Upgrade
|
| Net Cash Per Share | -12.35 | -3.43 | -0.75 | -1.20 | -2.08 | Upgrade
|
| Filing Date Shares Outstanding | 29.06 | 29.06 | 29.06 | 29.06 | 29.06 | Upgrade
|
| Total Common Shares Outstanding | 29.06 | 29.06 | 29.06 | 29.06 | 29.06 | Upgrade
|
| Working Capital | 179.62 | 35.72 | 50.04 | 24.7 | 2.89 | Upgrade
|
| Book Value Per Share | 7.61 | 6.12 | 5.32 | 4.25 | 3.14 | Upgrade
|
| Tangible Book Value | -181.21 | 28.65 | 52.21 | 25.21 | -2.46 | Upgrade
|
| Tangible Book Value Per Share | -6.24 | 0.99 | 1.80 | 0.87 | -0.08 | Upgrade
|
| Machinery | - | 1.03 | 0.99 | 2.14 | 1.43 | Upgrade
|
Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.